Skip to content

Quick ratio at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.5×-0.1×
Stryker logo
StrykerSYK
1.3×+0.3×
IAR
Integra LifeSciencesIART
+1.2×
Solventum logo
SolventumSOLV
0.7×-0.1×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
1.8×+0.3×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
4.9×+1.4×

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Calculated from Sanara MedTech Inc.’s reported figures.

Based on the most recent quarter.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s quick ratio?
Sanara MedTech Inc. (SMTI) reported quick ratio of 2× in Q1 2026.
How has Sanara MedTech Inc.'s quick ratio changed year-over-year?
Sanara MedTech Inc.'s quick ratio decreased by 19.2% year-over-year, from 2.5× to 2×.
What is the long-term trend for Sanara MedTech Inc.'s quick ratio?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s quick ratio has grown at a 11.0% compound annual growth rate (CAGR), from 0.9× to 1.6×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.